Stardust Power Hires Mr. Bruce Czachor as General Counsel
Globenewswire· 2026-01-26 12:30
Core Viewpoint - Stardust Power Inc. has appointed Mr. Bruce Czachor as General Counsel to enhance its legal and governance framework as the company progresses towards constructing a lithium refinery in Muskogee, Oklahoma [2][7]. Company Overview - Stardust Power Inc. is focused on developing battery-grade lithium carbonate to strengthen America's energy security by establishing resilient supply chains [8]. - The company is developing a lithium processing facility in Muskogee, Oklahoma, with an expected production capacity of up to 50,000 metric tons per annum of battery-grade lithium carbonate [8]. Leadership Appointment - Mr. Bruce Czachor brings over 30 years of experience in legal, corporate governance, and executive leadership within publicly listed energy and mining companies [3]. - His previous role was as Executive Vice President and Chief Legal Officer at Piedmont Lithium Inc., where he advised on corporate strategy, governance, and M&A, and led a successful cross-border public merger [3][4]. - Czachor's extensive experience in the lithium sector and his established global network are expected to strengthen Stardust Power's leadership team [4]. Educational Background - Mr. Czachor holds a J.D., magna cum laude, from New York Law School and a B.A. in Political Science from Binghamton University [6]. - He completed a Corporate Governance certification from the Wharton School in 2023 and is licensed to practice in New York, New Jersey, and California [6]. Management Commentary - CEO Roshan Pujari expressed that Czachor's expertise in corporate governance and capital markets makes him a valuable addition to the leadership team, particularly as the company advances its Muskogee refinery project [7]. - Czachor himself expressed enthusiasm about joining Stardust Power at a pivotal moment in the company's growth [7].
North American Niobium Corp. Announces Addition of Mining Executive Olivier Tavchandjian to Board of Directors
Globenewswire· 2026-01-26 12:30
Core Viewpoint - North American Niobium and Critical Minerals Corp. has appointed Olivier Tavchandjian to its Board of Directors, enhancing its expertise in mineral resource evaluation and exploration strategy [1][5]. Company Overview - North American Niobium and Critical Minerals Corp. focuses on the acquisition and development of precious, base, and critical mineral assets, including properties in British Columbia and Quebec [7]. Appointment Details - Olivier Tavchandjian is currently the Senior Vice President at Hudbay Minerals Inc., with over 35 years of experience in mineral resource estimation and exploration strategy [2][3]. - His background includes significant involvement in multi-billion-dollar greenfield projects and large-scale mining expansions, which will support the company's critical mineral projects [3]. Strategic Initiatives - The company plans to form a Technical Committee to provide oversight and strategic guidance for the evaluation and advancement of its exploration and critical mineral properties [5]. - North American Niobium has recently closed flow-through financings totaling $4.8 million, ensuring full funding for its 2026 exploration program [5]. Stock Options - The company has granted stock options to Mr. Tavchandjian, exercisable at $1.20 per share for five years, with a vesting period of 16 months [6].
Deep Sea Minerals Corp. Completes Name Change and Provides Industry Update
Globenewswire· 2026-01-26 12:30
Vancouver, BC, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Deep Sea Minerals Corp. (CSE: SEAS) (OTCPK: CUHRF) (FSE: X45) ("Deep Sea" or the "Company") is pleased to announce that, further to its news releases on January 20, 2026 and January 23, 2026, the Company has completed its name change to “Deep Sea Minerals Corp.”The Company’s common shares (the “Shares”) have begun trading on the Canadian Securities Exchange today under the new stock symbol “SEAS” and under the new name of the Company. The new CUSIP is 24378A1 ...
K Wave Media Completes Acquisition of Rabbit Walk
Globenewswire· 2026-01-26 12:30
Targeting 25 to 30 percent revenue growth over the next 12 monthsNEW YORK and SEOUL, South Korea, Jan. 26, 2026 (GLOBE NEWSWIRE) -- K Wave Media (NASDAQ: KWM), a publicly traded media and entertainment company with a Bitcoin treasury, today announced the successful closing of its first acquisition since its Nasdaq listing in 2025. K Wave Media’s acquisition of Rabbit Walk, a leading visual effects, AI powered advertising, and 3D content studio, strengthens K Wave Media’s creative portfolio, broadens its glo ...
MKS Announces Proposed Private Offering of €1.0 Billion of Senior Notes
Globenewswire· 2026-01-26 12:27
Core Viewpoint - MKS Inc. plans to offer €1.0 billion in senior notes due 2034 to refinance existing debt and improve its capital structure [1][2]. Group 1: Offering Details - The offering will consist of unsecured senior notes, guaranteed by certain subsidiaries of MKS [2]. - The notes will be sold to qualified institutional buyers under Rule 144A and to non-U.S. persons outside the United States under Regulation S [3]. Group 2: Use of Proceeds - MKS intends to use the net proceeds from the offering, along with funds from refinancing existing loans, to prepay approximately $1.3 billion of the USD Tranche B Term Loan and fully refinance both the USD and Euro Tranche B Term Loans [2].
Maple Gold Announces $12 Million Brokered Life Offering and a Concurrent $4 Million Non-Brokered Private Placement
Globenewswire· 2026-01-26 12:11
Not for distribution to United States news wire services or for dissemination in the United States VANCOUVER, British Columbia, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Maple Gold Mines Ltd. (TSX-V: MGM) (OTCQX: MGMLF) (FSE: M3G0) ("Maple" or the "Company") announces today that it has entered into an agreement pursuant to which Canaccord Genuity Corp. has agreed to act as lead agent and sole bookrunner, for and on behalf of a syndicate of agents (the "Agents"), in connection with a best efforts private placement o ...
HBT Financial, Inc. Announces Fourth Quarter 2025 Financial Results
Globenewswire· 2026-01-26 12:05
Core Insights - HBT Financial, Inc. reported a net income of $18.9 million, or $0.60 diluted earnings per share, for Q4 2025, a decrease from $19.8 million, or $0.63 per share in Q3 2025, and $20.3 million, or $0.64 per share in Q4 2024 [2][10] - The company achieved an adjusted net income of $20.1 million, or $0.64 per diluted share, supported by strong balance sheet growth and asset quality [3][6] - The company is optimistic about 2026, anticipating solid performance and a successful merger with CNB Bank Shares, Inc. [5] Financial Performance - Net interest income for Q4 2025 was $50.5 million, up 1.1% from Q3 2025, and increased 6.6% from $47.4 million in Q4 2024 [7][8] - The net interest margin for Q4 2025 was 4.12%, slightly down from 4.13% in Q3 2025, but up from 3.96% in Q4 2024 [9][11] - Noninterest income for Q4 2025 was $9.9 million, a slight increase from $9.8 million in Q3 2025, but a decrease of 14.9% from $11.6 million in Q4 2024 [12][13] Asset Quality - Nonperforming assets totaled $8.7 million, or 0.17% of total assets, stable compared to previous quarters [22] - The company recorded net charge-offs of $0.8 million, or 0.10% of average loans on an annualized basis, an increase from $0.1 million in Q3 2025 [24] - The allowance for credit losses was 1.21% of total loans, with a coverage ratio of 552% for nonperforming loans [25] Capital and Liquidity - As of December 31, 2025, the company exceeded all regulatory capital requirements under Basel III, with total capital to risk-weighted assets at 16.82% [26] - The tangible book value per share increased to $17.20, a 16.2% increase over the past year [4] - The company repurchased 23,879 shares of common stock at a weighted average price of $24.33 during Q4 2025 [27] Loan and Deposit Growth - Total loans outstanding were $3.46 billion at December 31, 2025, reflecting a $56.2 million increase from Q3 2025 [18] - Total deposits were $4.36 billion, a slight increase from $4.35 billion in Q3 2025, driven by higher balances in retail and business accounts [19]
Coloplast A/S - Q1 2025/26 Earnings Release - Invitation for conference call on 6 Feb 2026 at 11.00am CET
Globenewswire· 2026-01-26 12:02
Core Insights - Coloplast will release its interim financial results for Q1 2025/26 on February 6, 2026, at approximately 07:30 am CET, followed by a conference call to discuss the results and answer questions from investors and analysts [1] Group 1: Conference Call Details - The conference call will be hosted by Coloplast's Interim CEO Lars Rasmussen, CFO Anders Lonning-Skovgaard, and Senior Director of Investor Relations Kristine Husted Munk, among others [2] - A presentation will be available on Coloplast's website about one hour before the conference call [1] - Participants can join the conference call via a webcast or register in advance to receive dial-in details for active participation in the Q&A session [2] Group 2: Contact Information - For further inquiries, Coloplast's Investor Relations team can be contacted, including Kristine Husted Munk and Simone Dyrby Helvind, with provided phone numbers and email addresses [3]
Sharps Technology Reports Strong Solana Staking Income
Globenewswire· 2026-01-26 12:00
NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (“STSS” or the “Company”), a medical device company implementing a Solana-based digital asset treasury strategy, today issued an update on its treasury and recent operational highlights. Treasury Updates Staking: Since inception, STSS’s validator partners have generated ~7% gross annual percentage yield (APY) before fees, outperforming the Solana network average. Nearly all of the Company’s SOL holdings are currently staked.Balance Sheet: S ...
ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture
Globenewswire· 2026-01-26 12:00
UNIONDALE, NY, Jan. 26, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and consumer products company, today provided an operational update on the progress of its Crown Medical Collections initiative relating to legacy COVID-19 testing receivables held by its laboratory subsidiaries currently in Chapter 11 proceedings. Crown Medical Collections (“Crown Medical”), which serves as special counsel to the Debtors for the collection of a ...